Emergent BioSolutions annual gross margin
2020
2021
2022
2023
Emergent BioSolutions Gross Margin Growth & History (EBS)
Emergent BioSolutions's gross margin was 30.27% for fiscal 2023.
View full Emergent BioSolutions company overviewEmergent BioSolutions annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | 30.27% | −4.01 pp |
| 2022 | 2022-12-31 | 34.27% | −15.98 pp |
| 2021 | 2021-12-31 | 50.25% | −9.23 pp |
| 2020 | 2020-12-31 | 59.48% | — |
Emergent BioSolutions quarterly gross margin
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2024 | 2024-09-30 | 54.87% | +22.63 pp |
| Q2 2024 | 2024-06-30 | −18.85% | −60.49 pp |
| Q1 2024 | 2024-03-31 | 49.20% | +46.22 pp |
| Q4 2023 | 2023-12-31 | 30.66% | +0.34 pp |
| Q3 2023 | 2023-09-30 | 32.24% | +0.85 pp |
| Q2 2023 | 2023-06-30 | 41.64% | +14.60 pp |
| Q1 2023 | 2023-03-31 | 2.98% | −43.61 pp |
| Q4 2022 | 2022-12-31 | 30.31% | −30.76 pp |
| Q3 2022 | 2022-09-30 | 31.39% | +2.63 pp |
| Q2 2022 | 2022-06-30 | 27.04% | −9.26 pp |
| Q1 2022 | 2022-03-31 | 46.59% | −18.25 pp |
| Q4 2021 | 2021-12-31 | 61.07% | — |
| Q3 2021 | 2021-09-30 | 28.75% | — |
| Q2 2021 | 2021-06-30 | 36.30% | — |
| Q1 2021 | 2021-03-31 | 64.84% | — |
Emergent BioSolutions gross margin trends
Across the available reported history, Emergent BioSolutions's gross margin decreased from 34.27% to 30.27%, a change of −4.01 percentage points. The latest reported quarter, Q3 2024, shows 54.87%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Emergent BioSolutions filings at SEC.gov ↗